Nosocomial pneumonia risk and stress ulcer prophylaxis: A comparison of pantoprazole vs ranitidine in cardiothoracic surgery patients

Chest

Volumn 136, Issue 2, 2009, Pages 440-447

  Miano, Todd A ^a,c   Reichert, Marc G ^b   Houle, Timothy T ^c   MacGregor, Drew A ^c   Kincaid, Edward H ^c   Bowton, David L ^c  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^b North Carolina Baptist Hospital   (United States)

^c WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PANTOPRAZOLE; RANITIDINE;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CRITICALLY ILL PATIENT; FEMALE; HOSPITAL INFECTION; HUMAN; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; PNEUMONIA; PRIORITY JOURNAL; RISK FACTOR; SCORING SYSTEM; STRESS ULCER; THORAX SURGERY; TREATMENT OUTCOME;

EID: 68849110222     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.08-1634     Document Type: Article

References (28)

1. Porzecanski I, Bowton DL. Diagnosis and treatment of ventilator- associated pneumonia. Chest 2006; 130:597-604
2. Tablan OC, Anderson LJ, Besser R, et al. Guidelines for preventing health-care-associated pneumonia, 2003: recommendations of the CDC and the Healthcare Infection Control Practices Advisory Committee. MMWR Recomm Rep 2004; 53:1-36
3. Cook DJ, Reeve BK, Guyatt GH, et al. Stress ulcer prophylaxis in critically ill patients: resolving discordant meta-analyses. JAMA 1996; 275:308-314
4. Messori A, Trippoli S, Vaiani M, et al. Bleeding and pneumonia in intensive care patients given ranitidine or sucralfate for prevention of stress-ulcer: meta-analysis of randomized controlled trials. BMJ 2000; 321:1103-1106
5. du Moulin GC, Paterson DG, Hedley-Whyte J, et al. Aspiration of gastric bacteria in antacid-treated patients: a frequent cause of postoperative colonization of the airway. Lancet 1982; 319:242-245
6. Donowitz LG, Page MC, Mileur BL, et al. Alteration of normal gastric flora in critical care patients receiving antacid and cimetidine therapy. Infect Control 1986; 7:23-26
7. Prod'hom G, Leuenberger P, Koerfer J, et al. Nosocomial pneumonia in mechanically ventilated patients receiving antacid, ranitidine, or sucralfate as prophylaxis for stress ulcer: a randomized controlled trial. Ann Intern Med 1994; 120:653-662
8. Cook D, Guyatt G, Marshall J, et al. A comparison of sucralfate and ranitidine for the prevention of upper gastrointestinal bleeding in patients requiring mechanical ventilation. N Engl J Med 1998; 338:791-797
9. Hsu TC, Su CF, Leu SC, et al. Omeprazole is more effective than a histamine H2-receptor blocker for maintaining a persistent elevation of gastric pH after colon resection for cancer. Am J Surg 2004; 187:20-23
10. Kantorova I, Svoboda P, Scheer P, et al. Stress ulcer prophylaxis in critically ill patients: a randomized controlled trial. Hepatogastroenterology 2004; 51:757-761
11. Laheij RJ, Sturkenboom MC, Hassing RJ, et al. Risk of community-acquired pneumonia and use of gastric acid-suppressive drugs. JAMA 2004; 292:1955-1960
12. Gulmez SE, Holm A, Frederiksen H, et al. Use of proton pump inhibitors and the risk of community-acquired pneumonia: a population-based case-control study. Arch Intern Med 2007; 167:950-955
13. Society of Thoracic Surgeons. Database. Available at: http://www.sts.org/sections/stsnationaldatabase/. Accessed June 1, 2009
14. Michalopoulos A, Tzelepis G, Dafni U, et al. Determinants of hospital mortality after coronary artery bypass grafting. Chest 1999; 115:1598-1603
15. Rady MY, Ryan T, Starr NJ. Perioperative determinants of morbidity and mortality in elderly patients undergoing cardiac surgery. Crit Care Med 1998; 26:225-235
16. Halkos ME, Puskas JD, Lattouf OM, et al. Impact of preoperative neurologic events on outcomes after coronary artery bypass grafting. Ann Thorac Surg 2008; 86:504-510
17. Magovern JA, Sakert T, Magovern GJ, et al. A model that predicts morbidity and mortality after coronary artery bypass graft surgery. J Am Coll Cardiol 1996; 28:1147-1153
18. Higgins TL, Estafanous FG, Loop FD, et al. Stratification of morbidity and mortality outcome by preoperative risk factors in coronary artery bypass patients: a clinical severity score. JAMA 1992; 267:2344-2348
19. Bonten MJ, Kollef MH, Hall JB. Risk factors for ventilator-associated pneumonia: from epidemiology to patient management. Clin Infect Dis 2004; 38:1141-1149
20. Shorr AF, Duh MS, Kelly KM, et al. Red blood cell transfusion and ventilator-associated pneumonia: a potential link? Crit Care Med 2004; 32:666-674
21. Turner JS, Morgan CJ, Thakrar B, et al. Difficulties in predicting outcome in cardiac surgery patients. Crit Care Med 1995; 23:1843-1850
22. Centers for Disease Control and Prevention. National Nosocomial Infections Surveillance System (NNIS). Available at: http://www.cdc.gov/ncidod/ dhqp/nnis.html. Accessed June 1, 2009
23. Rosenbaum PR, Rubin DB. The central role of the propensity score in observational studies for causal effects. Biometrika 1983; 70:41-55
24. D' Agostino RB Jr. Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Stat Med 1998; 17:2265-2281
25. Madl C, Kitzberger R, Warzawska J, et al. Effect of intravenous esomeprazole verus ranitidine on gastric pH in critically ill patients: a prospective, randomized, double blind, multicenter study [abstract]. Crit Care Med 2007; 35:A249
26. Thorens J, Froehlich F, Schwizer W, et al. Bacterial overgrowth during treatment with omeprazole compared with cimetidine: a prospective randomised double blind study. Gut 1996; 39:54-59
27. Conrad SA, Gabrielli A, Margolis B, et al. Randomized, double-blind comparison of immediate-release omeprazole oral suspension versus intravenous cimetidine for the prevention of upper gastrointestinal bleeding in critically ill patients. Crit Care Med 2005; 33:760-765
28. Safdar N, Dezfulian C, Callard HR, et al. Clinical and economic consequences of ventilator-associated pneumonia: a systematic review. Crit Care Med 2005; 33:2184-2193